Pharma Focus Asia
KP - Sustainable Packaging Solutions

Fujifilm Irvine Plans New Manufacturing Facility in Europe


Fujifilm Irvine Scientific announced plans to build a new manufacturing facility to accelerate the development in bioproduction, and cell and gene therapy markets in Tilburg, Netherlands.


This new facility will be the company’s third manufacturing site, joining two existing facilities in the United States and Japan.

The facility will occupy a 250,000 square foot building within FUJIFILM Manufacturing Europe B.V.

The facility is meant for cGMP manufacturing of animal component-free, dry powder media, liquid media, and downstream bioprocessing liquids, thereby adding additional production capacity for FUJIFILM Irvine Scientific of 320,000 Kg/year for dry powder, and 470,000 L/year for liquids. Water for Injection (WFI) will also be manufactured on the premises.

The construction work on the facility has commenced already and is expected to complete by the second half of 2021.


NameFujifilm Irvine Scientific
LocationTilburg, Netherlands
ScheduleScheduled to be completed by the second half of 2021
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?